Grifols to take full ownership of Alkahest in $146m deal

This article was originally published here

Alkahest is a clinical stage company that is focussed on the discovery and development of treatments for neurodegenerative and age-related diseases with therapies that target the aging plasma

The post Grifols to take full ownership of Alkahest in $146m deal appeared first on Pharmaceutical Business review.